These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1277 related articles for article (PubMed ID: 19201770)
1. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Ng EK; Chong WW; Jin H; Lam EK; Shin VY; Yu J; Poon TC; Ng SS; Sung JJ Gut; 2009 Oct; 58(10):1375-81. PubMed ID: 19201770 [TBL] [Abstract][Full Text] [Related]
2. Plasma miR-21: a potential diagnostic marker of colorectal cancer. Kanaan Z; Rai SN; Eichenberger MR; Roberts H; Keskey B; Pan J; Galandiuk S Ann Surg; 2012 Sep; 256(3):544-51. PubMed ID: 22868372 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening. Koga Y; Yasunaga M; Takahashi A; Kuroda J; Moriya Y; Akasu T; Fujita S; Yamamoto S; Baba H; Matsumura Y Cancer Prev Res (Phila); 2010 Nov; 3(11):1435-42. PubMed ID: 20959518 [TBL] [Abstract][Full Text] [Related]
4. Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer. Feng B; Xu WB; Zheng MH; Ma JJ; Cai Q; Zhang Y; Ji J; Lu AG; Qu Y; Li JW; Wang ML; Hu WG; Liu BY; Zhu ZG J Gastroenterol Hepatol; 2006 Oct; 21(10):1596-603. PubMed ID: 16928223 [TBL] [Abstract][Full Text] [Related]
5. miR-150 as a potential biomarker associated with prognosis and therapeutic outcome in colorectal cancer. Ma Y; Zhang P; Wang F; Zhang H; Yang J; Peng J; Liu W; Qin H Gut; 2012 Oct; 61(10):1447-53. PubMed ID: 22052060 [TBL] [Abstract][Full Text] [Related]
6. Molecular detection of circulating cancer cells in the peripheral blood of patients with colorectal cancer by using membrane array with a multiple mRNA marker panel. Yeh CS; Wang JY; Wu CH; Chong IW; Chung FY; Wang YH; Yu YP; Lin SR Int J Oncol; 2006 Feb; 28(2):411-20. PubMed ID: 16391796 [TBL] [Abstract][Full Text] [Related]
7. Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps. Wu CW; Ng SS; Dong YJ; Ng SC; Leung WW; Lee CW; Wong YN; Chan FK; Yu J; Sung JJ Gut; 2012 May; 61(5):739-45. PubMed ID: 21930727 [TBL] [Abstract][Full Text] [Related]
8. Development and evaluation of a colorimetric membrane-array method for the detection of circulating tumor cells in the peripheral blood of Taiwanese patients with colorectal cancer. Wang JY; Yeh CS; Chen YF; Wu CH; Hsieh JS; Huang TJ; Huang SY; Lin SR Int J Mol Med; 2006 May; 17(5):737-47. PubMed ID: 16596255 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA signatures: novel biomarker for colorectal cancer? Luo X; Burwinkel B; Tao S; Brenner H Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1272-86. PubMed ID: 21551242 [TBL] [Abstract][Full Text] [Related]
10. Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression. Pu XX; Huang GL; Guo HQ; Guo CC; Li H; Ye S; Ling S; Jiang L; Tian Y; Lin TY J Gastroenterol Hepatol; 2010 Oct; 25(10):1674-80. PubMed ID: 20880178 [TBL] [Abstract][Full Text] [Related]
11. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers. Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125 [TBL] [Abstract][Full Text] [Related]
12. Systematic identification and validation of candidate genes for detection of circulating tumor cells in peripheral blood specimens of colorectal cancer patients. Findeisen P; Röckel M; Nees M; Röder C; Kienle P; Von Knebel Doeberitz M; Kalthoff H; Neumaier M Int J Oncol; 2008 Nov; 33(5):1001-10. PubMed ID: 18949363 [TBL] [Abstract][Full Text] [Related]
13. A plasma microRNA panel for detection of colorectal adenomas: a step toward more precise screening for colorectal cancer. Kanaan Z; Roberts H; Eichenberger MR; Billeter A; Ocheretner G; Pan J; Rai SN; Jorden J; Williford A; Galandiuk S Ann Surg; 2013 Sep; 258(3):400-8. PubMed ID: 24022433 [TBL] [Abstract][Full Text] [Related]
14. [Clinicopathological significance of microRNA-21 and miR-125 expression in colorectal cancer]. Zhang Y; Zhou ZG; Wang L; Zhang P; Wang MJ; Cui CF; Guan JT; Chen KL; Zhan L Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Nov; 12(6):623-6. PubMed ID: 19921579 [TBL] [Abstract][Full Text] [Related]
15. Clinical potential role of circulating microRNAs in early diagnosis of colorectal cancer patients. Du M; Liu S; Gu D; Wang Q; Zhu L; Kang M; Shi D; Chu H; Tong N; Chen J; Adams TS; Zhang Z; Wang M Carcinogenesis; 2014 Dec; 35(12):2723-30. PubMed ID: 25239640 [TBL] [Abstract][Full Text] [Related]
16. Relationship between tumor and plasma levels of hTERT mRNA in patients with colorectal cancer: implications for monitoring of neoplastic disease. Terrin L; Rampazzo E; Pucciarelli S; Agostini M; Bertorelle R; Esposito G; DelBianco P; Nitti D; De Rossi A Clin Cancer Res; 2008 Nov; 14(22):7444-51. PubMed ID: 19010861 [TBL] [Abstract][Full Text] [Related]
17. Down-regulation of fecal miR-143 and miR-145 as potential markers for colorectal cancer. Li JM; Zhao RH; Li ST; Xie CX; Jiang HH; Ding WJ; Du P; Chen W; Yang M; Cui L Saudi Med J; 2012 Jan; 33(1):24-9. PubMed ID: 22273643 [TBL] [Abstract][Full Text] [Related]
18. Identification of Cystatin SN as a novel tumor marker for colorectal cancer. Yoneda K; Iida H; Endo H; Hosono K; Akiyama T; Takahashi H; Inamori M; Abe Y; Yoneda M; Fujita K; Kato S; Nozaki Y; Ichikawa Y; Uozaki H; Fukayama M; Shimamura T; Kodama T; Aburatani H; Miyazawa C; Ishii K; Hosomi N; Sagara M; Takahashi M; Ike H; Saito H; Kusakabe A; Nakajima A Int J Oncol; 2009 Jul; 35(1):33-40. PubMed ID: 19513549 [TBL] [Abstract][Full Text] [Related]
19. miRNA-199a-3p in plasma as a potential diagnostic biomarker for gastric cancer. Li C; Li JF; Cai Q; Qiu QQ; Yan M; Liu BY; Zhu ZG Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S397-405. PubMed ID: 22956063 [TBL] [Abstract][Full Text] [Related]
20. Circulating microRNAs as biomarkers of colorectal cancer: results from a genome-wide profiling and validation study. Giráldez MD; Lozano JJ; Ramírez G; Hijona E; Bujanda L; Castells A; Gironella M Clin Gastroenterol Hepatol; 2013 Jun; 11(6):681-8.e3. PubMed ID: 23267864 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]